Savant Capital LLC Has $2.35 Million Stake in Elevance Health, Inc. (NYSE:ELV)

Savant Capital LLC reduced its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 16.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,361 shares of the company's stock after selling 1,255 shares during the quarter. Savant Capital LLC's holdings in Elevance Health were worth $2,346,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lifeworks Advisors LLC increased its holdings in shares of Elevance Health by 2.5% in the third quarter. Lifeworks Advisors LLC now owns 1,037 shares of the company's stock valued at $539,000 after purchasing an additional 25 shares during the last quarter. Catalyst Financial Partners LLC increased its holdings in shares of Elevance Health by 2.9% in the third quarter. Catalyst Financial Partners LLC now owns 918 shares of the company's stock valued at $477,000 after purchasing an additional 26 shares during the last quarter. Fullcircle Wealth LLC increased its holdings in shares of Elevance Health by 1.5% in the third quarter. Fullcircle Wealth LLC now owns 1,743 shares of the company's stock valued at $906,000 after purchasing an additional 26 shares during the last quarter. Dunhill Financial LLC grew its stake in shares of Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after acquiring an additional 26 shares in the last quarter. Finally, TCI Wealth Advisors Inc. raised its stake in Elevance Health by 5.6% in the 3rd quarter. TCI Wealth Advisors Inc. now owns 506 shares of the company's stock worth $263,000 after purchasing an additional 27 shares in the last quarter. 89.24% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $485.00 price objective on shares of Elevance Health in a research note on Friday, January 24th. Wells Fargo & Company decreased their target price on shares of Elevance Health from $483.00 to $478.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. TD Cowen decreased their target price on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a report on Monday, October 21st. Truist Financial decreased their target price on shares of Elevance Health from $520.00 to $480.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, StockNews.com raised shares of Elevance Health from a "hold" rating to a "buy" rating in a report on Tuesday, February 4th. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Elevance Health has an average rating of "Moderate Buy" and an average target price of $517.03.

Elevance Health Trading Down 0.5 %

ELV traded down $2.02 during trading on Friday, reaching $389.58. 1,202,248 shares of the company's stock were exchanged, compared to its average volume of 1,761,671. Elevance Health, Inc. has a one year low of $362.21 and a one year high of $567.26. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $90.35 billion, a PE ratio of 15.21, a price-to-earnings-growth ratio of 1.17 and a beta of 0.83. The firm has a fifty day moving average price of $385.08 and a two-hundred day moving average price of $448.71.

Elevance Health (NYSE:ELV - Get Free Report) last posted its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, topping analysts' consensus estimates of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. As a group, equities research analysts forecast that Elevance Health, Inc. will post 34.05 earnings per share for the current fiscal year.

Elevance Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be given a $1.71 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.76%. This is an increase from Elevance Health's previous quarterly dividend of $1.63. Elevance Health's payout ratio is 25.46%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.